ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Organogenesis Holdings Inc

Organogenesis Holdings Inc (ORGO)

2,42
-0,06
(-2,42%)
Chiuso 06 Giugno 10:00PM
2,42
0,00
(0,00%)
Dopo le ore di negoziazione: 1:59AM

Organogenesis Holdings Inc (ORGO) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2025-01-10Mr. Brian GrowChief Commercial Officer958,001,19kDerivative Exercise and Retained Stock1,24483,69k0,20%
2026-03-09Mr. Arthur S. LeibowitzLead Independent Director5,00k13,41kAcquisto2,68242,19k2,11%
2026-03-09Dr. Michael Joseph DriscollIndependent Director10,00k26,69kAcquisto2,67--
2026-03-01Mr. Robert CavorsiChief Business Officer-700,002,25kSale to Issuer3,21275,52k-0,25%
2026-02-18Mr. Antonio S. MontecalvoInsider-3,78k14,51kSale to Issuer3,84107,02k-3,41%
2026-02-18Mr. Brian GrowChief Commercial Officer-11,89k45,65kSale to Issuer3,84368,56k-3,12%
2026-02-18Mr. Gary S. GillheeneyPresident, CEO, Chair of the Board-91,31k350,63kSale to Issuer3,842,24M-3,91%
2026-02-18Mr. Patrick BilboCOO-16,38k62,88kSale to Issuer3,84603,77k-2,64%
2026-02-18Mr. David C. FranciscoCFO-14,69k56,40kSale to Issuer3,84271,33k-5,13%
2026-02-18Mr. Robert CavorsiChief Business Officer-5,49k21,07kSale to Issuer3,84276,22k-1,95%
2026-02-18Ms. Lori H. FreedmanChief Administrative & Legal Officer-14,41k55,34kSale to Issuer3,84522,35k-2,68%
2026-02-15Mr. Patrick BilboCOO-64,41k240,26kSale to Issuer3,73571,04k-10,14%
2026-02-15Mr. David C. FranciscoCFO-52,45k195,63kSale to Issuer3,73241,98k-17,81%
2026-02-15Mr. Robert CavorsiChief Business Officer-17,66k65,86kSale to Issuer3,73171,51k-9,33%
2026-02-15Mr. Gary S. GillheeneyPresident, CEO, Chair of the Board-271,41k1,01MSale to Issuer3,732,15M-11,23%
2026-02-15Ms. Lori H. FreedmanChief Administrative & Legal Officer-54,74k204,19kSale to Issuer3,73523,93k-9,46%
2026-02-15Mr. Brian GrowChief Commercial Officer-43,96k163,97kSale to Issuer3,73331,63k-11,70%
2026-02-15Mr. Antonio S. MontecalvoInsider-18,62k69,45kSale to Issuer3,7377,91k-19,29%
2025-12-16Mr. Glenn H. NussdorfDirector-200,00k1,03MVendita5,1411,75M-1,67%
2025-11-24Mr. Glenn H. NussdorfDirector-300,00k1,59MVendita5,29 - 5,3411,95M-2,45%
2025-05-14Mr. Glenn H. NussdorfDirector358,50k1,10MAcquisto2,99 - 3,0912,25M3,02%
2025-06-09Mr. Glenn H. NussdorfDirector-22,78k80,80kVendita3,50 - 3,5612,25M-0,19%
2025-08-11Mr. Brian GrowChief Commercial Officer1,89k4,66kDerivative Exercise and Retained Stock2,47202,42k0,94%
2025-08-11Mr. Brian GrowChief Commercial Officer-2,17k4,66kDerivative Exercise and Sale2,47 - 4,62202,42k-
2025-07-16Mr. Robert CavorsiChief Business Officer-360,001,61kSale to Issuer4,47189,17k-0,19%
2025-06-04Ms. Lori H. FreedmanChief Administrative & Legal Officer252,26k725,29kAcquisto2,82 - 2,99419,71k150,65%